NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | Healthcare | Biotechnology | 4.87% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.85% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 4.19% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.97% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 3.93% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.92% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.92% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.90% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.85% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.83% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 3.52% |
| DYN | Dyne Therapeutics Inc | Healthcare | Biotechnology | 3.49% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 3.48% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.21% |
| HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |